News
Coronavirus (SARS-CoV) Testing
We have established a Coronavirus / SARS-CoV-2 screening program for companies based on QPCR of swabs – no clinical testing.
We have established a Coronavirus / SARS-CoV-2 screening program for companies based on QPCR of swabs – no clinical testing.
Minerva Analytix offers GMP-compliant and rapid biosafety testing using state-of-the-art molecular biology methods to prevent and contain biological contamination in your applications.
© All rights reserved